Virtus ETF Advisers LLC Rigel Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $247,002 - $373,643	-104,662 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $33,579 - $43,173	-9,594 Reduced 8.4%	104,662 $380,000
Q2 2021 Aug 10, 2021	BUY	$3.09 - $4.54 $68,860 - $101,173	22,285 Added 24.23%	114,256 $496,000
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $5,410 - $7,961	1,615 Added 1.79%	91,971 $315,000
Q4 2020 Feb 12, 2021	SELL	$2.35 - $3.74 $190,065 - $302,487	-80,879 Reduced 47.23%	90,356 $316,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $41,559 - $96,427	-23,348 Reduced 12.0%	171,235 $411,000
Q2 2020 Aug 05, 2020	BUY	$1.41 - $2.05 $47,020 - $68,363	33,348 Added 20.68%	194,583 $356,000
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $29,851 - $70,515	-23,505 Reduced 12.72%	161,235 $252,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $295,584 - $448,918	184,740 New	184,740 $395,000
Q4 2018 Feb 05, 2019	SELL	$2.08 - $3.36 $486,755 - $786,297	-234,017 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $41,683 - $57,554	16,032 Added 7.35%	234,017 $751,000
Q2 2018 Aug 10, 2018	BUY	$2.83 - $4.11 $14,441 - $20,973	5,103 Added 2.4%	217,985 $617,000
Q1 2018 May 14, 2018	BUY	$3.54 - $4.54 $404,112 - $518,268	114,156 Added 115.63%	212,882 $754,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $89,338 - $118,933	-27,659 Reduced 21.88%	98,726 $383,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $25,200 - $29,709	11,560 Added 10.07%	126,385 $321,000
Q2 2017 Aug 14, 2017	BUY	N/A	114,825	114,825 $313,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.95B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.